Premium
The Direct Cost of Type 1 Diabetes Mellitus in Israel
Author(s) -
Stern Z.,
Levy R.
Publication year - 1994
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.1994.tb02031.x
Subject(s) - medicine , diabetes mellitus , indirect costs , disease , direct cost , total cost , intensive care medicine , surgery , pediatrics , endocrinology , accounting , business , economics , microeconomics
Estimates of the cost of Type 1 (insulin‐dependent) diabetes mellitus should take into account the development of various complications. In this study, we calculated separately the basic direct costs of a Type 1 diabetic patient over a span of 35 years of living with the disease, and on average, the cost of complications which developed during this period of time. Assessment of costs showed that there is a difference between the cost of treating the disease itself, which decreases over the years, and the cost of treating its complications, which increases. The cost of treating one patient over the 35‐year period amounted to about £247 000 in 1993 prices, and in terms of discount value, to about £104 000. These costs are significant in planning the health expenditure and the investment of resources for prevention of the disease, and in selecting proper methods of treatment of complications.